Find the Perfect Plan for Your Investment Journey
A
Latest price
52 Week Range
€15.62 - €35.14
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Latest price
Market Cap | €3.84B |
EV | €5.30B |
Shares Outstanding | 225.32M |
Beta | 0.74 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €26.98 |
P/E 2025E | 18.54x |
P/Revenue 2025E | 1.48x |
Revenue | 7.30% |
EPS | -2.10% |
Operating Cash Flow | -0.80% |
Free Cash Flow | 6.20% |
Revenue | 7.00% |
EPS | 11.10% |
Operating Cash Flow | 9.70% |
Free Cash Flow | 1.40% |
Gross Margin 2025E | 78.75% |
Net Profit Margin 2025E | 7.08% |
ROE 2025E | 17.56% |
ROCE 2024 | 12.92% |
DPS 2025E | €0.34 |
Payout Ratio 2025E | 37.36% |
Div. Yield 2025E | 2.00% |
DPS Last 3Y CAGR | 3.70% |
Price
%
1M
3M
6M
1Y
3Y
5Y
A
Amplifon S.p.A.
AMP
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Vita, Enrico
Employees
13,337
Website
corporate.amplifon.comIPO Date
2001-10-01
Headquarters
Via Ripamonti 133, Milan, Milan, 20141, Italy
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved